Evidence map›Paper›PMID 40488860›Full record

ArticleEuropean journal of applied physiology2025

Reliability and applicability of the

Damir Zubac, Timo Niels, Freerk T Baumann

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of applied physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Damir ZubacDepartment of Internal Medicine 1, Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, University Hospital of Cologne, Cologne, Germany. damir.zubac@uk-koeln.de.ORCID http://orcid.org/0000-0003-4204-4207
Timo NielsDepartment of Internal Medicine 1, Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, University Hospital of Cologne, Cologne, Germany.
Freerk T BaumannDepartment of Internal Medicine 1, Center for Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, University Hospital of Cologne, Cologne, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to examine the reliability and applicability of the

methodsPatients receiving ICI therapy (n = 13, 46 ± 15 y, BMI = 24.3 ± 2.6) and age-matched controls (n = 13, 47 ± 18 y, BMI = 24.9 ± 4.5) completed all study procedures. Following medical clearance, they performed a ramp CPET on a cycle ergometer until task failure. During the second visit, they completed three consecutive step-transition tests: 6 min at 20 W, followed by 6 min at 90% of gas exchange threshold (GET), and continuing to 30-min constant-load cycling, with gas exchange and cardiovascular responses constantly monitored.

resultsThe control group reached ~ 30% higher peak power output, resulting in higher peak values of minute ventilation (

conclusionsApparently, the

Indexed as

Heart RateImmune Checkpoint InhibitorsImmunotherapyNeoplasmsOxygen ConsumptionAdultExercise TestFemaleHumansMaleMiddle AgedReproducibility of ResultsImmune Checkpoint InhibitorsChemotherapyExercise intoleranceExercise oncologyOxygen uptake kinetics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.